Knowledge of potential harms and benefits of tamoxifen among women considering breast cancer preventive therapy

THORNELOE, Rachael, HALL, Louise, WALTER, Fiona, SIDE, Lucy, LLOYD, Kelly and SMITH, Samuel (2020). Knowledge of potential harms and benefits of tamoxifen among women considering breast cancer preventive therapy. Cancer Prevention Research.

[img] PDF
Thorneloe_KnowledgeOfPotential(AM).pdf - Accepted Version
Restricted to Repository staff only until 27 January 2021.
All rights reserved.

Download (685kB)
Official URL: https://cancerpreventionresearch.aacrjournals.org/...
Link to published version:: https://doi.org/10.1158/1940-6207.CAPR-19-0424
Related URLs:

    Abstract

    Tamoxifen reduces breast cancer incidence in women at increased risk, but may cause side-effects. We examined women’s knowledge of tamoxifen’s potential harms and benefits, and the extent to which knowledge reflects subjective judgements of awareness and decision quality. After a hospital appointment, 408 (55.7%) women at increased risk of breast cancer completed a survey assessing objective knowledge about the potential benefit (risk reduction) and harms (endometrial cancer, thromboembolic events, and menopausal side-effects) of tamoxifen, and subjective tamoxifen knowledge and decisional quality. 258 (63.2%) completed a 3-month follow-up survey. 15.7% of participants recognised the potential benefit and three major harms of using tamoxifen. These women were more likely to have degree level education (vs. below degree level) (OR=2.24, 95%CI: 1.11-4.55) and good numeracy (vs. poor numeracy) (OR=5.91, 95%CI: 1.33-26.19). Tamoxifen uptake was higher in women who recognised all harms and benefits (vs. not recognising) (OR=2.47, 95%CI: 0.94–6.54). 65.8% of tamoxifen users were unaware of its potential benefit and harms. Most (87.1%) women reported feeling informed about tamoxifen, and subjective decisional quality was high (Mean [SD], 17.03 [1.87], out of 18). Knowledge regarding the potential harms and benefit of tamoxifen is low in women considering prevention therapy, and they may need additional support to make informed decisions about tamoxifen preventive therapy.

    Item Type: Article
    Uncontrolled Keywords: Oncology & Carcinogenesis; 1103 Clinical Sciences; 1112 Oncology and Carcinogenesis
    Identification Number: https://doi.org/10.1158/1940-6207.CAPR-19-0424
    SWORD Depositor: Symplectic Elements
    Depositing User: Symplectic Elements
    Date Deposited: 07 Jan 2020 11:19
    Last Modified: 04 Feb 2020 11:32
    URI: http://shura.shu.ac.uk/id/eprint/25637

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics